Cyclacel Pharmaceuticals (CYCC) Institutional Ownership $0.34 -0.01 (-1.73%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$0.34 +0.00 (+0.59%) As of 02/21/2025 06:22 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)CurrentInstitutional OwnershipPercentage23.58%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$217.08KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$20.97K Get CYCC Insider Trade Alerts Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CYCC Institutional Buying and Selling by Quarter Cyclacel Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2024 Armistice Capital LLC134,000$217K0.0%N/A9.178% 5/10/2024 Acadian Asset Management LLC14,285$29K0.0%-41.0%1.084% 11/1/2022 Kestra Advisory Services LLC23,000$34K0.0%N/A0.183% 10/25/2022Raymond James Financial Services Advisors Inc.20,806$30K0.0%-32.5%0.166% 10/18/2022 McIlrath & Eck LLC26,342$38K0.0%N/A0.210% 8/15/2022 Sio Capital Management LLC454,355$491K0.2%+7.5%4.546% 2/10/2022 Acadian Asset Management LLC23,242$89K0.0%N/A0.233% 11/16/2021 Two Sigma Advisers LP121,500$640K0.0%+929.7%1.316% 11/15/2021 Pura Vida Investments LLC105,141$554K0.0%-33.2%1.139% 11/15/2021 Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663% Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/12/2021 Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332% 11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108% 10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160% 8/18/2021 Ikarian Capital LLC100,000$593K0.0%-66.7%1.083% 8/17/2021 Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114% 8/17/2021 Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716% 8/16/2021 Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393% 8/16/2021 Schonfeld Strategic Advisors LLC102,525$607K0.0%-25.0%1.110% 8/16/2021 Maven Securities LTD234,500$1.43M0.1%-6.2%2.540% 8/13/2021 Northern Trust Corp14,957$89K0.0%N/A0.162% 8/13/2021 Geode Capital Management LLC50,860$301K0.0%+143.3%0.551% 8/13/2021 Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548% 7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094% 5/19/2021 Virtu Financial LLC13,108$93K0.0%+27.3%0.142% 5/19/2021 Squarepoint Ops LLC23,836$169K0.0%N/A0.258% 5/18/2021 Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491% 5/18/2021 Verition Fund Management LLC116,674$830K0.0%N/A1.264% 5/18/2021 Morgan Stanley100,000$711K0.0%-13.0%1.083% 5/18/2021 Citadel Advisors LLC293,867$2.09M0.0%N/A3.182% 5/18/2021 Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707% 5/17/2021 Schonfeld Strategic Advisors LLC136,725$972K0.0%N/A1.481% 5/17/2021 Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505% 5/17/2021 Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249% 5/12/2021 Geode Capital Management LLC20,904$148K0.0%N/A0.226% 5/12/2021 Pura Vida Investments LLC273,958$1.95M0.1%-42.3%2.967% 5/11/2021 Acadian Asset Management LLC34,057$242K0.0%N/A0.369% 4/12/2021 Valeo Financial Advisors LLC4,500$32K0.0%N/A0.063% 2/24/2021 Virtu Financial LLC10,293$80K0.0%N/A0.212% 2/16/2021 Pura Vida Investments LLC475,000$3.71M0.1%N/A9.766% 2/16/2021 Acuta Capital Partners LLC150,000$1.17M0.3%N/A3.084% Collect $7k per month from Tesla’s SECRET dividend (Ad)There's a little-known secret about Tesla that even seasoned investors don't know. Despite not paying a traditional dividend, there's a way to collect up to $7,013 per month from Tesla… starting as early as next month. This backdoor strategy is changing the game for smart investors. Want to see how it works?Click here to uncover Tesla's hidden income secret.2/12/2021Raymond James Financial Services Advisors Inc.57,006$445K0.0%+24.6%1.172% 2/12/2021 Ikarian Capital LLC391,450$3.06M0.1%N/A8.048% (Data available from 1/1/2016 forward) CYCC Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CYCC shares? During the previous two years, the following institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals shares: Armistice Capital LLC ($217K), Acadian Asset Management LLC ($29K).Learn more on CYCC's institutional investors. What percentage of Cyclacel Pharmaceuticals stock is owned by institutional investors? 23.58% of Cyclacel Pharmaceuticals stock is owned by institutional investors. Learn more on CYCC's institutional investor holdings. Which institutional investors have been buying Cyclacel Pharmaceuticals stock? The following institutional investors have purchased Cyclacel Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($134K). How much institutional buying is happening at Cyclacel Pharmaceuticals? Institutional investors have bought a total of 134,000 shares in the last 24 months. This purchase volume represents approximately $217.08K in transactions. Which Cyclacel Pharmaceuticals major shareholders have been selling company stock? The following institutional investors have sold Cyclacel Pharmaceuticals stock in the last 24 months: Acadian Asset Management LLC ($9.94K). How much institutional selling is happening at Cyclacel Pharmaceuticals? Institutional investors have sold a total of 9,938 shares in the last 24 months. This volume of shares sold represents approximately $20.97K in transactions. Related Companies Edesa Biotech Institutional Ownership Psyence Biomedical Institutional Ownership Biofrontera Institutional Ownership Aytu BioPharma Institutional Ownership Cyclerion Therapeutics Institutional Ownership Creative Medical Technology Institutional Ownership AIM ImmunoTech Institutional Ownership Dogwood Therapeutics Institutional Ownership Indaptus Therapeutics Institutional Ownership NLS Pharmaceutics Institutional Ownership This page (NASDAQ:CYCC) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CYCC Stock Alerts